Prescription Pharmacy Rx News
Health Highlights: Jan. 10, 2012
Here are some of the latest health as well as health examination news developments, compiled by the editors of HealthDay: $1,000 Genome Mapping Soon Available, Company Says A U.S. genomics company says it will be capable to offer $1,000 genome sequencing by the end of the year.
California-based Life Technologies Corp. is expected to introduce Tuesday a machine that can map a person's entire genetic makeup for $1,000 as well as deliver the information within a day, the Wall Street Journal reported. Currently, the cheapest genome sequencing costs about $3,000 as well as takes a week. A large reduction in cost could be a major step in advancing the take of DNA to develop personalized medicine. Some experts believe it will eventually be routine to take a patient's genetic code to guide prevention as well as treatment of health problems throughout life, the WSJ reported. ----- Intel Exploring Recent Speech Technology for Stephen Hawking A research project to help reverse the slowing of speech being experienced by physicist Stephen Hawking is being undertaken by chip maker Intel Corp., a senior company executive says. Speaking on the sidelines of a conference celebrating Hawking's 70th birthday, Intel Essential Technology Officer Justin Rattner told the Associated Press that the company had a team in England to look at ways to help the famed British scientist communicate more quickly. The team's task was to gather data for further study, Rattner explained. Hawking has amyotrophic lateral sclerosis, as well as known as Lou Gehrig's disease, which causes muscle weakness, slurred speech as well as paralysis. Since he lost his voice in 1985, Hawking has used an infrared sensor attached to his glasses that translates pulses in his fair cheek into words spoken by a voice synthesizer. But, the nerves in his face possess deteriorated as well as his rate of speech has slowed to about a word a minute, the AP reported. This means a recent approach is needed, Rattner said. Likely solutions include eye or brainwave tracking technology or high definition cameras that can detect minute movements in Hawking's face to synthesize his speech. ----- Powerful Recent Painkillers Could Lead to More Destructive Robberies: Senator Market approval of recent types of "super painkillers" currently under review by the U.S. Food as well as Drug Administration could lead to an increase in destructive robberies by people who want to sell the drugs on the streets, warns U.S. Senator Charles Schumer. "It's tremendously concerning that at the alike time policymakers as well as law enforcement professionals are waging a war on the growing prescription drug crisis, recent super-drugs could well be on their way, flooding the market," Schumer, D-N.Y., told the Associated Press. "The FDA needs to grab the reins as well as unhurried down the stampede to introduce these powerful narcotics." Recent destructive robberies involving prescription painkillers possess west six people not alive. On Recent Year's Eve, a robber as well as a federal agent died during a robbery at a Extended Island pharmacy. Final June, a heist of 11,000 hydrocodone pills at another Extended Island pharmacy resulted in four deaths. Tests are currently underway on four drugs that contain a more powerful version of hydrocodone, one of the most abused painkillers in the U.S., the AP reported. Incase the FDA approves these drugs, Schumer said their needs to be "robust post-market surveillance" of the drugs as they are marketed, advertised as well as sold. ----- Drug Maker Recalls Bottles of Excedrin, NoDoz, Bufferin as well as Gas-X Certain bottles of the over-the-counter medicines Excedrin, NoDoz, Bufferin as well as Gas-X are being recalled because they may contain stray pills from other medicines, or chipped or destroyed tablets, Novartis said Sunday. The recall includes bottles of Excedrin as well as NoDoz with expiration dates of Dec. 20, 2014 or earlier, as well as packages of Bufferin as well as Gas-X with expiration dates of Dec. 20, 2013 or earlier, the Associated Press reported. More information is available on the company website as well as customers can as well as consult Novartis at 1-888-477-2403 Monday to Friday, 9 a.m. to 8 p.m. EST. The recall announcement follows Novartis' recent decision to temporarily halt production at its Lincoln, Neb. plant for "maintenance as well as other improvement activities," the AP reported. -----  Copyright © 2012 HealthDay. All rights reserved.
Related Medications and Drug Categories:Related Rx NewsPeople Tend to Choose Friends Just Similar Themselves - September 27, 2011 02:01:54
Phobias Slideshow Pictures
Depression Tips Slideshow Pictures
Gene Therapy a Boon for 6 Hemophilia Patients - December 13, 2011 02:01:44
Take the Blood as well as Bleeding Disorders Quiz!
By Maureen SalamonHealthDay Report
Mistaken Beliefs About Cancer Abound - August 28, 2008 12:01:04
Mistaken Beliefs About Cancer AboundWEDNESDAY, Aug. 27 (HealthDay News) — People throughout the world possess major misconceptions when it comes to what causes cancer, recent research suggests.
CDC, Aventis Pasteur plan targeted flu vaccine delivery - June 17, 2008 05:18:37
High-priority providers to get supplies first; hospital pharmacies report shortages, attempted price gouging.
CDC Director Julie Gerberding, MD, MPH, and Aventis Pasteur
Traditional Chinese Therapy May Help Ease Eczema - March 16, 2009 12:01:03
Traditional Chinese Therapy May Help Ease Eczema
Skin Problems Slideshow
SATURDAY, March 14 (Health
|
